Back

Antiarrhythmic drugs, catheter ablation or minimally-invasive surgical ablation for treating persistent atrial fibrillation: a systematic review and meta-analyses

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Atrial fibrillation ablation Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Ms Eva Meulendijks

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))

33 More presentations in this session

Presentation thumbnail
P-wave duration in sinus rhythm correlates to extent of left atrial low-voltage and predicts outcome of pulmonary vein isolation in persistent atrial fibrillation
Doctor B. Mueller-Edenborn (Bad Krozingen, DE)
Abstract Slides
Presentation thumbnail
The long-term efficacy of concomitant Maze IV surgery in patients with atrial fibrillation
Miss C. Engelsgaard (Odense, DK)
Abstract Slides
Presentation thumbnail
The impact of early recurrence of atrial tachyarrhythmias after pulmonary antrum isolation for non-paroxysmal atrial fibrillation
Doctor K. Kaitani (Otsu, JP)
Abstract
Presentation thumbnail
Not all non-paroxysmal atrial fibrillation drivers are included in complex fractionated electrogram area or low-voltage area: ExTRa Mapping project
Doctor K. Sakata (Takatsuki, JP)
Abstract
Presentation thumbnail
Left atrial linear ablation negatively affects atrial function.
Miss S. Baalman (Amsterdam, NL)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Atrial fibrillation ablation

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources